MULTIMAX
Live / Applied — Statement of use — registration review complete (as of 30 Mar 2026)
What this means for you
Not registered yet, but its 06 Sept 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98167519
- Mark type
- Stylized text
- Filed
- 06 Sept 2023
- Published for opposition
- 20 Aug 2024
- Attorney of record
- John G. Tutunjian
Goods and services
- Class 005 — Pharmaceuticals: Drug delivery agents in the form of pharmaceutical creams for use as a transdermal delivery system that facilitate the delivery of active pharmaceutical ingredients for a wide variety of pharmaceuticals for use in compounding
Owner
- Xenex Laboratories Inc., Coquitlam, BC, CA
- Xenex Laboratories Inc., Coquitlam, BC, CA
Prosecution history
- 30 Mar 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 30 Mar 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 29 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 26 Sept 2025 — USE AMENDMENT FILED
- 27 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 26 Sept 2025 — TEAS STATEMENT OF USE RECEIVED
- 16 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Apr 2025 — SOU EXTENSION 1 GRANTED
- 15 Apr 2025 — SOU EXTENSION 1 FILED
- 15 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 20 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 Aug 2024 — PUBLISHED FOR OPPOSITION
- 31 Jul 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Jul 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER